Researchers at the University of Cologne and the Center for Genomic Regulation (CRG) in Barcelona have discovered that cancer ...

Tumors with a larger volume, as estimated by the AI model, were associated with a higher risk of treatment failure and metastasis, independent of other factors that are normally used to estimate this ...

HOUSTON -- Progression-free survival (PFS) in IDH -mutant low-grade glioma remained twice as high in adults who received ...

Onc.AI, a digital health company developing AI-driven oncology clinical management solutions, announced that results from a study evaluating the use o ...

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...

Presented Encouraging Phase 2 Data on NUC-7738 in Combination with Pembrolizumab at the European Society for Medical Oncology (ESMO) Congress ...

Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in ...